Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

Voice disorders were linked to a higher risk of later cognitive decline in a large health-record study

Original source

Voice Disorders as Early Biomarkers of Cognitive Decline.J Voice · 11 August 2026 (opens in a new tab)

Compass summarised this from the study's abstract.

Study details

Studied in
Human

Population inferred from the title and abstract by Compass.

Article

View article on the publisher's site (opens in a new tab)via the publisher — full text availability varies

People diagnosed with voice disorders had a higher risk of incident cognitive decline than matched controls in a study of 833,417 patients. The association was also seen when voice disorders were compared with hearing loss alone, and was strongest when both conditions were present. The study included amyotrophic lateral sclerosis (ALS) among neurological conditions previously associated with voice changes, but it did not test voice disorders as a cognitive biomarker specifically in people with ALS.

Why this matters

Voice problems may be a possible point at which clinicians consider cognitive assessment, according to the study. This does not show that voice treatment prevents cognitive decline, or that the finding changes ALS treatment. Further research would be needed to test whether the association applies to people with ALS and whether treating voice disorders affects cognition.

Limitations and context

This was an observational analysis of diagnosed conditions in the TriNetX US Collaborative Health Network, so it shows an association rather than causation. The source does not provide detailed information here about the participants’ ages, disease causes, follow-up methods, or how cognitive decline and voice disorders were diagnosed. The study was not an ALS-specific study, and its authors said the possible cognitive benefits of early voice treatment still need investigation.

Summarised by Compass 11 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Bibliographic data from PubMed is courtesy of the U.S. National Library of Medicine. Compass does not reproduce source abstracts and may not reflect the most current record.

Relevant to you?